Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | — | — | — | — | — | — | — | — | +5.85% |
| Total return | — | — | — | — | — | — | — | — | +5.85% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Jun 12, 2025. Past performance does not guarantee future results.
Fees
| Net expense ratio | — | Annual cost of a $10,000 investment | — |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Apr 17, 2023 — portfolio reporting date from the data provider; holdings are not live positions. 533 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Apollo Medical Holdings, Inc. | AMEH | 0.43% | 1.07K | $55.5K |
| 2 | Avid Technology, Inc. | AVID | 0.36% | 1.35K | $46.5K |
| 3 | Kindred Biosciences, Inc. | KIN | 0.33% | 5.28K | $42.6K |
| 4 | IDT Corporation | IDT | 0.31% | 1.22K | $40.0K |
| 5 | The Joint Corp. | JYNT | 0.28% | 505 | $36.1K |
| 6 | RadNet, Inc. | RDNT | 0.28% | 1.18K | $36.1K |
| 7 | Raven Industries, Inc. | RAVN | 0.27% | 694 | $34.9K |
| 8 | XPEL, Inc. | XPEL | 0.27% | 447 | $34.9K |
| 9 | VBI Vaccines Inc. | VBIV | 0.27% | 9.98K | $34.9K |
| 10 | Chiasma, Inc. | CHMA | 0.27% | 9.11K | $34.9K |
| 11 | Crocs, Inc. | CROX | 0.27% | 347 | $34.9K |
| 12 | Akebia Therapeutics, Inc. | AKBA | 0.26% | 9.21K | $33.6K |
| 13 | CyberOptics Corporation | CYBE | 0.26% | 986 | $33.6K |
| 14 | SiTime Corporation | SITM | 0.26% | 286 | $33.6K |
| 15 | Cornerstone Building Brands, Inc. | CNR | 0.26% | 2.04K | $33.6K |
| 16 | Ferro Corporation | FOE | 0.25% | 1.70K | $32.3K |
| 17 | Denali Therapeutics Inc. | DNLI | 0.25% | 498 | $32.3K |
| 18 | BioLife Solutions, Inc. | BLFS | 0.25% | 827 | $32.3K |
| 19 | Boot Barn Holdings, Inc. | BOOT | 0.25% | 429 | $32.3K |
| 20 | Cactus, Inc. | WHD | 0.25% | 940 | $32.3K |
| 21 | Domo, Inc. | DOMO | 0.25% | 441 | $32.3K |
| 22 | Intra-Cellular Therapies, Inc. | ITCI | 0.25% | 852 | $32.3K |
| 23 | Customers Bancorp, Inc. | CUBI | 0.24% | 871 | $31.0K |
| 24 | Catalyst Pharmaceuticals, Inc. | CPRX | 0.24% | 5.94K | $31.0K |
| 25 | CAI International, Inc. | CAI | 0.24% | 633 | $31.0K |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | — | Paid (last 12 months) | — |
| Frequency | Semi-Annual | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Jun 01, 2021 | Last payment | $0.0520 |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Jun 01, 2021 | — | — | $0.0520 |
| Dec 29, 2020 | Dec 30, 2020 | Jan 05, 2021 | $0.2980 |
| Dec 01, 2020 | Dec 02, 2020 | Dec 07, 2020 | $0.0770 |
| Sep 01, 2020 | Sep 02, 2020 | Sep 08, 2020 | $0.0640 |
| Jun 01, 2020 | Jun 02, 2020 | Jun 05, 2020 | $0.1250 |
| Mar 02, 2020 | Mar 03, 2020 | Mar 06, 2020 | $0.0610 |
| Dec 27, 2019 | — | — | $0.0400 |
| Sep 03, 2019 | Sep 04, 2019 | Sep 09, 2019 | $0.1010 |
| Jun 03, 2019 | Jun 04, 2019 | Jun 07, 2019 | $0.1170 |
| Mar 01, 2019 | Mar 04, 2019 | Mar 07, 2019 | $0.0760 |
| Dec 27, 2018 | — | — | $0.0580 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
Liquidity
| Volume today | 93 | Average volume | 51 |
| AUM | $13.0M | Premium/Discount | — |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for PQSG
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.
PQSG